These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3621801)

  • 1. Relationship between subcutaneous blood flow and absorption of lente type insulin.
    Hildebrant P; Mehlsen J; Birch K; Kühl C
    Diabetes Res; 1987 Apr; 4(4):179-81. PubMed ID: 3621801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthostatic changes in subcutaneous blood flow and insulin absorption.
    Hildebrandt P; Birch K; Sestoft L; Nielsen SL
    Diabetes Res; 1985 Jul; 2(4):187-90. PubMed ID: 3910326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion and polymerization determines the insulin absorption from subcutaneous tissue in diabetic patients.
    Hildebrandt P; Sejrsen P; Nielsen SL; Birch K; Sestoft L
    Scand J Clin Lab Invest; 1985 Dec; 45(8):685-90. PubMed ID: 3909370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients.
    Hildebrandt P
    Acta Physiol Scand Suppl; 1991; 603():41-5. PubMed ID: 1789128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Monotard insulin: dose-dependent subcutaneous absorption.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Diabetes Res; 1984 Nov; 1(4):183-5. PubMed ID: 6529890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption of 125I-labelled protamine insulin from subcutaneous tissue].
    Petersen HD
    Ugeskr Laeger; 1978 Jul; 140(29):1760-4. PubMed ID: 684916
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV; Belovanova IM; Romanovskaia GA; Kasymov UA
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract]   [Full Text] [Related]  

  • 9. Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.
    Diaz-Pereda L; Yang TI; Knowles HC
    Trans Am Clin Climatol Assoc; 1979; 90():102-8. PubMed ID: 516224
    [No Abstract]   [Full Text] [Related]  

  • 10. Type I diabetes and insulin therapy.
    Hirsch IB; Farkas-Hirsch R
    Nurs Clin North Am; 1993 Mar; 28(1):9-23. PubMed ID: 8451220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcutaneous absorption of human and bovine ultralente insulin formulations.
    Hildebrandt P; Berger A; Vølund A; Kühl C
    Diabet Med; 1985 Sep; 2(5):355-9. PubMed ID: 2951089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow.
    Hildebrandt P; Birch K
    Diabet Med; 1988; 5(5):434-40. PubMed ID: 2970915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry.
    Vora JP; Burch A; Peters JR; Owens DR
    Diabet Med; 1993 Oct; 10(8):736-43. PubMed ID: 8261756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of 4-iodoantipyrine-125-I after subcutaneous injection in various regions.
    Munck O; Andersen AM; Binder C
    Scand J Clin Lab Invest Suppl; 1967; 99():39-45. PubMed ID: 6056931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of using the Kety method in determining the intensity of tissue blood flow].
    Davydova LI
    Med Radiol (Mosk); 1980 Jul; 25(7):65-8. PubMed ID: 7401961
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.